Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Molecular Diagnostic Techniques | 1 | 2009 | 335 | 0.270 |
Why?
|
| Communicable Diseases | 1 | 2009 | 210 | 0.270 |
Why?
|
| Vaginal Smears | 1 | 2007 | 183 | 0.260 |
Why?
|
| Placenta | 2 | 2019 | 562 | 0.240 |
Why?
|
| Gammaproteobacteria | 1 | 2024 | 20 | 0.230 |
Why?
|
| Papillomaviridae | 1 | 2007 | 646 | 0.220 |
Why?
|
| Hand Injuries | 1 | 2023 | 18 | 0.210 |
Why?
|
| Lacerations | 1 | 2023 | 35 | 0.210 |
Why?
|
| Lasers | 1 | 2023 | 238 | 0.200 |
Why?
|
| Fungi | 1 | 2023 | 148 | 0.200 |
Why?
|
| Phage Therapy | 1 | 2021 | 23 | 0.200 |
Why?
|
| Mycoplasma genitalium | 1 | 2021 | 2 | 0.200 |
Why?
|
| Mycoplasma Infections | 1 | 2021 | 9 | 0.200 |
Why?
|
| Bacteriuria | 1 | 2022 | 84 | 0.190 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 207 | 0.160 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 229 | 0.160 |
Why?
|
| Blood Culture | 1 | 2019 | 32 | 0.160 |
Why?
|
| Gram-Positive Bacteria | 1 | 2019 | 68 | 0.160 |
Why?
|
| Enema | 1 | 2018 | 50 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2007 | 1015 | 0.150 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 342 | 0.150 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2018 | 161 | 0.150 |
Why?
|
| Zika Virus | 1 | 2019 | 149 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 508 | 0.140 |
Why?
|
| Zika Virus Infection | 1 | 2019 | 173 | 0.140 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 1069 | 0.120 |
Why?
|
| Clostridium Infections | 1 | 2018 | 261 | 0.120 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 432 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 1297 | 0.110 |
Why?
|
| Health Care Costs | 1 | 2019 | 701 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 632 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 1050 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 708 | 0.100 |
Why?
|
| Pregnancy | 5 | 2024 | 8110 | 0.090 |
Why?
|
| Nucleic Acid Probes | 1 | 2009 | 2 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 90 | 0.080 |
Why?
|
| Government Regulation | 1 | 2009 | 59 | 0.080 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 142 | 0.080 |
Why?
|
| Heart Failure | 1 | 2021 | 2380 | 0.080 |
Why?
|
| Genome, Bacterial | 1 | 2009 | 211 | 0.080 |
Why?
|
| Quality Control | 1 | 2009 | 467 | 0.070 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2007 | 70 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2009 | 605 | 0.070 |
Why?
|
| Primary Health Care | 2 | 2024 | 844 | 0.070 |
Why?
|
| False Negative Reactions | 1 | 2007 | 295 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 725 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2007 | 379 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 5193 | 0.060 |
Why?
|
| Reference Values | 1 | 2007 | 1149 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 613 | 0.060 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2024 | 74 | 0.060 |
Why?
|
| Prevalence | 2 | 2022 | 3417 | 0.060 |
Why?
|
| Ciprofloxacin | 1 | 2024 | 90 | 0.060 |
Why?
|
| ROC Curve | 1 | 2007 | 1247 | 0.050 |
Why?
|
| Drug Resistance, Multiple | 1 | 2024 | 221 | 0.050 |
Why?
|
| Fluoroquinolones | 1 | 2024 | 131 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 4503 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2023 | 206 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 2495 | 0.050 |
Why?
|
| Humans | 12 | 2024 | 271967 | 0.050 |
Why?
|
| Macrolides | 1 | 2021 | 65 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 2578 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2023 | 835 | 0.050 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 1069 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2020 | 150 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2021 | 157 | 0.040 |
Why?
|
| Immunoassay | 1 | 2020 | 214 | 0.040 |
Why?
|
| Term Birth | 1 | 2019 | 34 | 0.040 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2019 | 23 | 0.040 |
Why?
|
| Pediatrics | 1 | 2009 | 1187 | 0.040 |
Why?
|
| RNA, Bacterial | 1 | 2019 | 84 | 0.040 |
Why?
|
| Freeze Drying | 1 | 2018 | 31 | 0.040 |
Why?
|
| Capsules | 1 | 2018 | 54 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 3177 | 0.040 |
Why?
|
| Equipment Contamination | 1 | 2019 | 86 | 0.040 |
Why?
|
| Female | 7 | 2024 | 149251 | 0.040 |
Why?
|
| Metagenomics | 1 | 2019 | 121 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2021 | 424 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 4989 | 0.040 |
Why?
|
| Genomics | 1 | 2009 | 2824 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2018 | 172 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 562 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2024 | 1310 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2019 | 1060 | 0.040 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 239 | 0.030 |
Why?
|
| Health Expenditures | 1 | 2019 | 202 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2019 | 274 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2023 | 2288 | 0.030 |
Why?
|
| Microcephaly | 1 | 2019 | 334 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1407 | 0.030 |
Why?
|
| Algorithms | 1 | 2007 | 3926 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 680 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 521 | 0.030 |
Why?
|
| Premature Birth | 1 | 2019 | 406 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 1621 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 920 | 0.030 |
Why?
|
| Adult | 4 | 2022 | 81964 | 0.030 |
Why?
|
| Microbiota | 1 | 2019 | 546 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1602 | 0.020 |
Why?
|
| Young Adult | 2 | 2019 | 22167 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2944 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8631 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2021 | 39817 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 7832 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 6515 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 18028 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 13398 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 4237 | 0.020 |
Why?
|
| Middle Aged | 2 | 2024 | 90447 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 7925 | 0.010 |
Why?
|
| Male | 2 | 2024 | 129048 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 31062 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 73494 | 0.010 |
Why?
|